Gender differences in psychiatric research are becoming more widely recognized, and changes in levels of the steroid hormone, oestrogen, over the menstrual or oestrous cycle are becoming increasingly implicated in alterations in cognitive strategies and capacities. The aim of this study is to investigate the interaction between oestrogen, NMDA receptor function and cognitive processing in rats. Forty-five mature female hooded-Lister rats received vehicle, 0.5, 5 or 10 μg/kg of oestradiol benzoate (EB, s.c. in olive oil) 24 h prior to an acute dose of 2 mg/kg phencyclidine (PCP, i.p. in 0.9% w/v saline), or vehicle (0.9% saline). After 30 min following PCP treatment, animals completed the novel object recognition task with a 1 min inter-trial interval to assess object recognition memory. Results show that 5 and 10 μg/kg of EB 24 h prior to 2 mg/kg PCP significantly (P < 0.01 and < 0.001, respectively) protected against the cognitive impairing effect of PCP in contrast to vehicle and 0.5 μg/kg EB plus PCP (not significant). EB may exert a neuromodulatory effect in this animal model leading to attenuation of the PCP-induced impairment in object recognition memory, suggesting an interaction between the gonadal steroids and NMDA receptor-mediated cognitive dysfunction, which is of potential relevance to schizophrenia.
Abdul-Monim Z., Reynolds G.P., Neill J.C. (2003) The atypical antipsychotic ziprasadone, but not haloperidol, improves PCP-induced cognitive deficits in a reversal learning task. J Psychopharmacol17: 57-66
2.
Abdul-Monim Z., Reynolds G.P., Neill J.C. (2006) The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal learning paradigm . Behav Brain Res169(2): 263-273
3.
Abdul-Monim Z., Neill J.C., Reynolds G.P. (2007) Sub-chronic PCP induces a deficit in reversal learning and in parvalbumin-immunoreactive GABAergic neurons in the rat. J Psychopharmacology21: 198-205
4.
Almieda A., Osvaldo P. (1999) Sex playing with the mind: effects of oestrogen and testosterone on mood and cognition. Arq Neuro-Psyqiatr57(3a): 701-706
5.
Birzniece V., Backstrom T., Johansson I.M., Lindblad C., Lundgren P., Lofgren M., Osson T., Ragagnin G., Taube M., Turkmen S., Wahlstrom G., Wang M., Wihlback A.C., Zhu D. (2006) Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. Brain Res Rev51: 212-239
6.
Bourne G.W., Capek R., Esplin B. (1995) Phencyclidine suppresses hippocampal long term potentiation through stereospecific activation of phencyclidine receptors . Neuropharm28: 49-56
7.
Daniel J.M., Dohanich D.P. (2001) Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in the CA1 of the hippocampus and the associated improvement in working memory. J Neurosci21(17): 6949-6956
8.
Dere E., Huston J.P., De Souza Silva M.A. (2007) The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Behav Rev, 31(5): 673-704
9.
Dohanich G.P., Fader A.J., Jarvorsky D.J. (1994) Estrogen and estrogen-progesterone treatments counteract the effect of scopolamine on reinforced T-maze alternation in female rats . Beh Neurosci108(5): 988-992
10.
Fader A.J., Johnson E E M, Donanich G.P. (1999) Estrogen improves working but not reference memory and prevents amnesic effects of scopolamine on a radial-arm maze. Pharmacol Biochem Behav62(4): 711-717
11.
Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. (2001) Neuroprotection by estradiol. Progress Neurobiol63: 29-63
12.
Gazzaley A.H., Weiland N.G., McEwen B.S., Morrison J.H. (1996) Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J Neurosci16: 6830-6838
13.
Goff M.D., Donald C., Joseph T., Coyle M.D. (2001) The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry158: 1367-1377
14.
Grayson B., Idris N.F., Neill J.C. (2007) Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Behav Brain Res doi:10.1016/j.bbr.2007.06. 012
15.
Green M.F., Nuechterlein K.H. (2004) The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schiz Res72: 1-3
16.
Green P.S., Simpkins J.W. (2000) Neuroprotective effects of estrogens; potential mechanisms of action. Int J Dev Neurosci18: 347-358
17.
Hafner H. (2003) Gender differences in schizophrenia. Psychoneuroendocrinology28(S2): 17-54
18.
Halbreich U., Khan L.S. (2003) Hormonal aspects of schizophrenia: an overview . Psychoneuroendocrinology28(2): 1-16
19.
Jentsch J.D., Roth R.H. (1999) The neuropsychopharmacology of Phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of Schizophrenia. Neuropsychopharmacology20(3): 201-225
20.
Idris N.F., Repeto P., Neill J.C., Large C.H. (2005) Investigation into the effects of lamotrigine and clozapine to improve reversal learning impairments induced by acute PCP and d-amphetamine in the rat. Psychopharmacology179: 336-348
21.
Kulkarni J. (2004) Oestrogen treatment for schizophrenia. Australasian Sci77: 25-26
22.
Kulkarni J., Castella A., Smith D. (1996) A clinical trial of the effects of estrogen in acutely psychotic women. Schiz Res20: 247-252
23.
Kulkarni J., White S., de Castella A., Fitzgerald P. (2000) Estrogen treatment in women with Schitzophrenia: Psychotic symptom and cognitive response. Schiz Res41(1): 28
24.
Kulkarni J., Reidel A., Castella A., Fitzgerald P.B., Rolfe T.J., Taffe J., Burger H. (2001) Estrogen - a potential treatment for schizophrenia . Schiz Res48(1): 137-144
25.
Liao D.L., Chen H., Lee S.M., Tsai S.J. (2002) Estrogen supplementation for female schizophrenics treated with atypical antipsychotics. Gen Hosp Psychiatry24(5): 357-359
26.
McDermott J.L., Liu L., Dluzen D.E. (1994) Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Exp Neurol125: 306-311
27.
McEwen B.S. (1991) Non-genomic and genomic effects of steroids on neural activity. Trends Pharm Sci12: 141-146
28.
Moriarty P.J., Lieber D., Bennett A., White L., Parrella M., Harvey P.D. (2001) Gender differences in poor outcome patients with lifelong schizophrenia. Schiz Bull27: 103-113
29.
Olney J.W., Newcomer J.W., Farber N.B. (1999) NMDA receptor hypofunction model of scizopherenia . J Psych Res33: 523-533
30.
Rao M.L., Kolsch H. (2003) Effects of estrogen on brain development and neuroprotection - implications for negative symptoms in schizophrenia. Psychoneuroendocrinology28(2): 83-96
31.
Reynolds G.P., Zhang Z.J., Beasley C.L. (2001) Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity . Brain Res Bull55(5): 579-584
32.
Reynolds G.P., Abdul-Monim Z., Neill J.C., Zhang Z.J. (2004) Calcium binding protein markers of GABA deficits in schizophrenia - post mortem studies and animal models. Neurotox Res6(1): 1-6
33.
Riecher-Rossler A., Hafner H. (2000) Gender aspects in schizophrenia: bridging the border between social and biological psychiatry. Acta Psychiatr Scand102(Suppl. 407): 58-62
34.
Riecher-Rossler A., Hafner H., Dutsch-Strobel A., Oster M., Stumbaum M., Van Gulick Balier M., Loffler W. (1994) Further evidence for a specific role of estradiol in schizophrenia? Biol Psych36: 492-494
35.
Sutcliffe J.S., Marshall K.M., Neill J.C. (2007) Influence of gender on working and spatial memory in the novel object recognition task in the rat. Behav Brain Res177: 117-125
36.
Tanabe F., Miyasaka N., Kubota T., Takeshi A. (2004) Estrogen and progesterone improve scopolamine-induced impairment of spatial memory. J Med Dent Sci51: 89-98
37.
Vongher J.M., Frye C.A. (1999) Progesterone in conjunction with estradiol has neuroprotective effects in an animal model of neurodegeneration. Pharmacol Biochem Behav64(4): 777-785
38.
Woolley C.S. (1998) Estrogen-mediated structural and functional synaptic plasticity in the female rat hippocampus. Horm Behav34(2): 140-148
39.
Woolley C.S., McEwen B.S. (1992) Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci12(7): 2549-2554
40.
Woolley C.S., McEwen B.S. (1993) Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat . J Comp Neurol336: 293-306
41.
Woolley C.S., Weiland N.G., McEwen B.S., Schwartzkroin P.A. (1997) Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci17: 1848-1959
42.
Zola S.M., Squire L. R, Teng E., Stefanacci L., Buffalo E.A., Clark R. E (2000) Impaired recognition memory in monkeys after damage limited to the hippocampal region. J Neurosci20(1): 451-463
43.
Zola-Morgan S., Squire L.R., Amaral D.G. (1986) Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to the field CA1 of the hippocampus. J Neurosci6: 2950-2967
